Stock Price
2,180.00
Daily Change
100.00 4.81%
Monthly
14.77%
Yearly
47.35%
Q1 Forecast
1,839.16

GlaxoSmithKline reported GBP90.44B in Market Capitalization this February of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
AbbVie USD 383.66B 20.17B Feb/2026
Alcon AG USD 29.11B 5.61B Sep/2025
Almirall EUR 2.29B 527.4M Jun/2025
Amgen USD 184.41B 32.48B Feb/2026
argenx SE USD 44.32B 15.63B Sep/2025
AstraZeneca USD 233.07B 17.56B Sep/2025
Bayer EUR 27.23B 2.14B Sep/2025
Biogen USD 20.54B 2.13B Sep/2025
Bristol-Myers Squibb USD 118.91B 9.1B Feb/2026
Eli Lilly USD 1.05T 36.63B Feb/2026
Fresenius EUR 26.7B 2.66B Sep/2025
Fresenius Medical Care EUR 13.1B 1.17B Sep/2025
Galapagos EUR 1.92B 355.84M Sep/2025
Genmab DKK 80.88B 7.82B Jun/2025
Gilead Sciences USD 137.73B 184M Sep/2025
GlaxoSmithKline GBP 87.33B 12.98B Feb/2026
Glaxosmithkline GBP 106.96B 20.08B Feb/2026
GRIFOLS EUR 7.49B 1.16B Sep/2025
Hikma Pharmaceutical USD 6.06B 1.64B Jun/2025
Lonza CHF 39.68B 980.61M Jun/2025
Merck EUR 47.59B 239.13M Sep/2025
Merck USD 293.38B 83.74B Feb/2026
Novartis USD 265.66B 9.48B Sep/2025
Novo Nordisk A/S DKK 1.54T 86.62B Feb/2026
Orion EUR 9.18B 190.08M Sep/2025
Pfizer USD 147.57B 12.48B Feb/2026
Philips EUR 22.19B 2.53B Sep/2025
Recordati EUR 10.81B 168.23M Sep/2025
Regeneron Pharmaceuticals USD 81.12B 21.53B Dec/2025
Roche Holding CHF 266.34B 55.46B Dec/2025
Sanofi EUR 100.88B 4.46B Dec/2025
Smith & Nephew USD 3.93B 9.39B Jan/2026
UCB EUR 32.47B 4.91B Jun/2025